Welcome to our Evotec Blog.

Hope you will find our articles and resources relevant for your projects and interests.

Our experts are available for any additional information and to assist with your project challenges!

Just contact us.

 

 

Blogs

Year

    2018

    Evotec repays 50% of € 140 m acquisition loan
    Nerina Coppini, 31 July 2018

    Strong operational cashflow facilitates repayment of € 70 M within the first year of the loan term € 140 M loan was taken to expand Evotec's value chain with Aptuit in August 2017

    Evotec receives milestone payment for start of Phase II trial in its multi-target alliance with Bayer
    Nerina Coppini, 19 July 2018

    Hamburg, Germany, 19 July 2018: Hamburg, Germany, 19 July 2018: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) announced today that its multi-target alliance with Bayer in the field of endometriosis has advanced a promising small molecule into Phase II clinical development for the treatment of chronic cough, resulting in a...

    Evotec confirm closing of transaction with Sanofi to accelerate infectious disease research and development
    Nerina Coppini, 3 July 2018

    Hamburg, Germany, 03 July 2018: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced that the strategic transaction signed on 15 June 2018, to integrate Sanofi’s infectious disease unit including licensing-in the majority of Sanofi’s infectious disease research portfolio, has been successfully closed with effect...

    All posts

     

     

    Contact us

    Evotec

    Business Development

    T +44.(0)1235.86 15 61 T +1.732 329 2355 x3308